. Author manuscript; available in PMC: 2017 Jun 2.

Published in final edited form as: J Biosci. 2016 Sep;41(3):419–426. doi: 10.1007/s12038-016-9631-z

Table 1.

Demographic and clinical characteristics of subjects

	Schizophrenic patients (N = 14) (mean±SD)	Healthy controls (N= 14) (mean±SD)
Age (years)	34.14±7.60	32.36±5.57
Gender (Male/Female)	8/6	6/8
Years of education	9.7 ± 3.8	11.3 ± 3.3
Duration of Illness (in weeks)	451.1 ± 318.8	NA
SANS total score	11.61 ± 5.9
SAPS total score	7.96 ± 4.3
Antipsychotic equivalent dosage of CPZ, mg/day	507.14 ± 362.9
Duration of antipsychotic drug taken (in weeks)	451.1 ± 318.8

SANS: Scale for the Assessment of Negative Symptoms; SAPS: Scale for the Assessment of Positive Symptoms; CPZ: chlorpromazine.